All Stories

  1. Antimalarials in Lupus Nephritis
  2. Treatment of IgA nephropathy: a rapidly evolving field
  3. Maintenance of Remission and Risk of Relapse in Myeloperoxidase Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Kidney Involvement
  4. Molecular Characterization of Membranous Nephropathy: Quo Vadis?
  5. Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy
  6. Use of anti-plasma cell antibody therapy in treatment of glomerular disease
  7. PEXIVAS
  8. Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach
  9. Persistent Microscopic Hematuria as a Risk Factor for Progression of IgA Nephropathy: New Floodlight on a Nearly Forgotten Biomarker
  10. Baseline and early outcomes in glomerular disease patients
  11. Circulating Complement Levels and C3 Glomerulopathy
  12. American Society of Nephrology Quiz and Questionnaire 2013: Glomerulonephritis
  13. A Patient with Nephrotic-Range Proteinuria and Focal Global Glomerulosclerosis
  14. American Society of Nephrology Quiz and Questionnaire 2012: Glomerulonephritis
  15. Laser Microdissection and Proteomic Analysis of Amyloidosis, Cryoglobulinemic GN, Fibrillary GN, and Immunotactoid Glomerulopathy
  16. Urinary Albumin Excretion Patterns of Patients with Cast Nephropathy and Other Monoclonal Gammopathy-Related Kidney Diseases
  17. Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy
  18. Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease